Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.

Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Cancer Epidemiol Biomarkers Prev. 2011 Mar; 20(3):522-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.